MORPHICTX.COM: Keyword Density Checker

Total words: 1455 | 2-word phrases: 381 | 3-word phrases: 413 | 4-word phrases: 427

PAGE INFO

Title	Try to keep the title under 60 characters (47 characters) Morphic Therapeutic – Morphic Therapeutic
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	small molecule inhibitors	5	1.21%
2	molecule inhibitors of	4	0.97%
3	pulmonary arterial hypertension	3	0.73%
4	in preclinical development	3	0.73%
5	governance sec filings	2	0.48%
6	press releases events	2	0.48%
7	releases events stock	2	0.48%
8	events stock information	2	0.48%
9	mint platform to	2	0.48%
10	the mint platform	2	0.48%
11	sec filings careers	2	0.48%
12	toggle overview press	2	0.48%
13	morphic is leveraging	2	0.48%
14	undisclosed integrin target	2	0.48%
15	morphic is developing	2	0.48%
16	of the integrin	2	0.48%
17	developing small molecule	2	0.48%
18	inhibitors of the	2	0.48%
19	overview press releases	2	0.48%
20	next generation α4β7	2	0.48%
21	for pulmonary arterial	2	0.48%
22	pipeline morf057 patients	2	0.48%
23	our pipeline morf057	2	0.48%
24	toggle our pipeline	2	0.48%
25	about menu toggle	2	0.48%
26	menu toggle our	2	0.48%
27	pipeline menu toggle	2	0.48%
28	menu toggle who	2	0.48%
29	integrin targets in	2	0.48%
30	toggle who we	2	0.48%

#	Keyword	Frequency	Density
1	small molecule inhibitors of	4	0.94%
2	developing small molecule inhibitors	2	0.47%
3	toggle our pipeline morf057	2	0.47%
4	press releases events stock	2	0.47%
5	overview press releases events	2	0.47%
6	toggle overview press releases	2	0.47%
7	the mint platform to	2	0.47%
8	governance sec filings careers	2	0.47%
9	for pulmonary arterial hypertension	2	0.47%
10	molecule inhibitors of the	2	0.47%
11	our pipeline morf057 patients	2	0.47%
12	menu toggle our pipeline	2	0.47%
13	pipeline menu toggle our	2	0.47%
14	inhibitors of the integrin	2	0.47%
15	who we are leadership	2	0.47%
16	toggle who we are	2	0.47%
17	menu toggle who we	2	0.47%
18	about menu toggle who	2	0.47%
19	releases events stock information	2	0.47%
20	treat autoimmune diseases cancer	1	0.23%
21	autoimmune diseases cancer and	1	0.23%
22	diseases cancer and fibrotic	1	0.23%
23	cancer and fibrotic diseases	1	0.23%
24	undisclosed target for pulmonary	1	0.23%
25	skip to content about	1	0.23%
26	to treat autoimmune diseases	1	0.23%
27	family to treat autoimmune	1	0.23%
28	targets across the integrin	1	0.23%
29	of targets across the	1	0.23%
30	inhibitors of targets across	1	0.23%
31	molecule inhibitors of targets	1	0.23%
32	relevant small molecule inhibitors	1	0.23%
33	platform to discover therapeutically	1	0.23%
34	target for pulmonary arterial	1	0.23%
35	to create small molecule	1	0.23%
36	pulmonary arterial hypertension morphic	1	0.23%
37	for evaluation as a	1	0.23%
38	pah is a devastating	1	0.23%
39	pah pah is a	1	0.23%
40	hypertension pah pah is	1	0.23%

#	URL	Whois	Check